Related Experiment Video
Updated: May 1, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Molecular mechanisms underlying oncogenic RET fusion in lung adenocarcinoma
Tatsuji Mizukami1, Kouya Shiraishi, Yoko Shimada
1*Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan; †Department of Radiation Oncology, Gunma University Graduate School of Medicine, Gunma, Japan; ‡Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan; §Division of Genetics, National Cancer Center Research Institute, Tokyo, Japan; and ¶Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Background:
Oncogenic RET fusion, caused by an inversion in chromosome 10, was recently identified as a driver mutation for the development of lung adenocarcinoma (LADC). Nevertheless, the molecular mechanism(s) underlying the rearrangement of the RET locus during lung carcinogenesis are unknown.
Methods:
Genomic segments containing breakpoint junctions for RET fusions were cloned and analyzed by genomic polymerase chain reaction and genome capture sequencing using a next-generation sequencer to identify the mechanisms involved in DNA strand breaks and illegitimate joining of DNA ends. Of the 18 cases studied, 16 were identified by screening 671 LADC cases and two were previously published.
Results:
Almost all (17 of 18, 94%) of the breakpoints in RET were located within a 2.0-kb region spanning exon 11 to intron 11 and no breakpoint occurred within 4 bp of any other. This suggested that as in papillary thyroid carcinoma, DNA strand breaks formed at nonspecific sites within this region trigger RET fusion. Just over half of the RET fusions in LADC (10 of 18, 56%) were caused by simple reciprocal inversion, and two DNA-repair mechanisms, namely nonhomologous end joining and break-induced replication, were deduced to have contributed to the illegitimate joining of the DNA ends.
Conclusions:
Oncogenic RET fusion in LADC occurs through multiple pathways and involves the illegitimate repair of DNA strand breaks through mechanisms different from those identified in papillary thyroid carcinoma, where RET fusion also functions as a driver mutation.
Insights
Oncogenic RET fusions in lung adenocarcinoma are driven by illegitimate DNA repair mechanisms, distinct from those in thyroid cancer. These fusions arise from non-specific DNA breaks and various repair pathways.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Oncogenic RET fusion is a driver mutation in lung adenocarcinoma (LADC).
- The molecular mechanisms behind RET gene rearrangement in lung cancer remain unclear.
Purpose of the Study:
- To investigate the molecular mechanisms of RET gene rearrangement in lung adenocarcinoma.
- To identify the DNA repair pathways involved in oncogenic RET fusion formation.
Main Methods:
- Cloning and analysis of genomic segments containing RET fusion breakpoint junctions.
- Utilizing genomic polymerase chain reaction and next-generation sequencing.
- Studied 18 LADC cases, with 16 identified from 671 LADC cases.
Main Results:
- RET fusion breakpoints predominantly occurred within a specific 2.0-kb region (exon 11 to intron 11).
- DNA strand breaks at non-specific sites within this region appear to trigger RET fusion.
- Nonhomologous end joining and break-induced replication were identified as key DNA repair mechanisms contributing to RET fusion.
Conclusions:
- Oncogenic RET fusion in LADC involves multiple pathways.
- Illegitimate repair of DNA strand breaks contributes to RET fusion in LADC.
- The mechanisms differ from those observed in papillary thyroid carcinoma, despite RET fusion also being a driver mutation there.
More Related Videos
09:49Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Abnormal Proliferation